The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
Test your knowledge about health facts, policy issues and proposals that are emerging among the 2020 presidential candidates. The 10 questions focus on health issues in the 2020 election, including: health care costs, prescription drug prices, the Affordable Care Act and changes in health insurance coverage, reproductive health, and Medicare-for-all and public option proposals.
Congress is considering proposals to subsidize COBRA coverage. We discuss the group market coverage that would be extended by COBRA subsidies, how COBRA costs and coverage compare to other common coverage options for those who lose job-based coverage (ACA Marketplace plans or Medicaid), and key considerations regarding COBRA subsidies for consumers and employers.
Enrolling in a new drug plan during the Medicare Open Enrollment period will disenroll you from your previous plan, so you don’t need to contact the previous plan to drop that coverage. You should notify the pharmacy where you fill your prescriptions so they can update their records with your new plan information.
This brief describes how the Medicare Part D benefit will change in 2020 under current law and proposed changes that would affect what beneficiaries, plans, manufacturers, and Medicare pay for drug costs under Part D in the future.
This brief analyzes Medicaid enrollment and spending trends for FY 2019 and FY 2020 based on interviews and data provided by state Medicaid directors as part of the 19th annual survey of Medicaid directors in all 50 states and the District of Columbia. States reported declines in Medicaid enrollment and modest growth in total Medicaid spending for state fiscal year (FY) 2019 and budgeted for nearly flat enrollment growth but a return to more typical…
Medicare does not cover routine dental care and about half of Medicare beneficiaries do not have dental coverage. This brief examines five potential ways to make oral health care more available and affordable for the Medicare population. This brief reviews the limits of dental coverage permitted under current Medicare law, then describes each of the policy options, with an analysis of likely implications for key stakeholders, including Medicare beneficiaries, taxpayers, insurers, and dental professionals
This issue brief provides a deeper look at telecontraception platforms, offering insights into the practices of 13 different companies that have attempted to make contraception more accessible outside of a clinical setting.
New federal legislation will require most private health plans to cover testing for the coronavirus with no cost sharing. Some states have adopted similar requirements for insurers they regulate, and many private insurance companies will voluntarily expand coverage for testing. However, some private coverage will not be subject to these requirements. To date, fewer changes have been adopted or considered with respect to treatment for complications from the disease. This brief reviews current coverage standards…
Among people with three consecutive years of coverage from a large employer, just 1.3 percent of enrollees accounted for 19.5 percent of overall health spending in 2017, finds a new KFF analysis. These “people with persistently high spending” – people in the top five percent of spending in each of the three years from 2015 to 2017 – had average health spending of $87,870 in 2017. That compared to average per person spending of $5,870…
Kaiser Health News regularly reports on news and issues involving prescription drugs and their costs. This page features some of their projects on related topics. Why The U.S. Remains The World’s Most Expensive Market For ‘Biologic’ Drugs, December 20, 2018 For The Asking, A Check Is In The Mail To Help Pay For Costly Drugs, December 13, 2018 Government Investigation Finds Flaws In the FDA’s Orphan Drug Program, November 30, 2018 Democrats Winning Key Leadership…
© 2026 KFF